183 related articles for article (PubMed ID: 31861604)
1. Management of Liver Oligometastatic Esophageal Cancer: Overview and Critical Analysis of the Different Loco-Regional Treatments.
Procopio F; Marano S; Gentile D; Da Roit A; Basato S; Riva P; De Vita F; Torzilli G; Castoro C
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861604
[TBL] [Abstract][Full Text] [Related]
2. Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer.
Matoska T; Banerjee A; Shreenivas A; Jurkowski L; Shukla ME; Gore EM; Linsky P; Gasparri M; George B; Johnstone C; Johnstone D; Puckett LL
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173988
[TBL] [Abstract][Full Text] [Related]
3. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Malthaner R; Fenlon D
Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
[TBL] [Abstract][Full Text] [Related]
4. Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review.
Kobayashi T; Ichiba T; Sakuyama T; Arakawa Y; Nagasaki E; Aiba K; Nogi H; Kawase K; Takeyama H; Toriumi Y; Uchida K; Kobayashi M; Kanehira C; Suzuki M; Ando N; Natori K; Kuraishi Y
Breast Cancer; 2012 Jul; 19(3):218-37. PubMed ID: 22532161
[TBL] [Abstract][Full Text] [Related]
5. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
Winter-Roach BA; Kitchener HC; Dickinson HO
Cochrane Database Syst Rev; 2009 Jan; (1):CD004706. PubMed ID: 19160239
[TBL] [Abstract][Full Text] [Related]
7. Detection and management of oligometastatic disease in oesophageal cancer and identification of prognostic factors: A systematic review.
Jamel S; Tukanova K; Markar S
World J Gastrointest Oncol; 2019 Sep; 11(9):741-749. PubMed ID: 31558978
[TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
9. Loco-Regional Therapies in Oligometastatic Adrenocortical Carcinoma.
Roux C; Boileve A; Faron M; Lamartina L; Delpla A; Tselikas L; Durand-Labrunie J; Hescot S; de Baere T; Hadoux J; Deschamps F; Baudin E
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681708
[TBL] [Abstract][Full Text] [Related]
10. An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma.
Bimonte S; Barbieri A; Palaia R; Leongito M; Albino V; Piccirillo M; Arra C; Izzo F
Infect Agent Cancer; 2015; 10():9. PubMed ID: 25755676
[TBL] [Abstract][Full Text] [Related]
11. [Role of loco-regional treatments for patients with breast cancer liver metastases].
Raimondi C; Danova M; Chatzileontiadou S; Palmeri L; Vercelli A; Palmeri S
Recenti Prog Med; 2009 Sep; 100(9):424-33. PubMed ID: 19886236
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer.
Urschel JD; Vasan H; Blewett CJ
Am J Surg; 2002 Mar; 183(3):274-9. PubMed ID: 11943125
[TBL] [Abstract][Full Text] [Related]
13. Management of single brain metastasis: a practice guideline.
Mintz A; Perry J; Spithoff K; Chambers A; Laperriere N
Curr Oncol; 2007 Aug; 14(4):131-43. PubMed ID: 17710205
[TBL] [Abstract][Full Text] [Related]
14. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Malthaner R; Fenlon D
Cochrane Database Syst Rev; 2003; (4):CD001556. PubMed ID: 14583936
[TBL] [Abstract][Full Text] [Related]
15. Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review.
Battaglia A; De Meerleer G; Tosco L; Moris L; Van den Broeck T; Devos G; Everaerts W; Joniau S
Eur Urol Oncol; 2019 Mar; 2(2):174-188. PubMed ID: 31017094
[TBL] [Abstract][Full Text] [Related]
16. Loco-regional recurrence from colon cancer: a population-based study.
Sjövall A; Granath F; Cedermark B; Glimelius B; Holm T
Ann Surg Oncol; 2007 Feb; 14(2):432-40. PubMed ID: 17139459
[TBL] [Abstract][Full Text] [Related]
17. Current treatment options for patients with initially unresectable isolated colorectal liver metastases.
Kanat O
World J Clin Oncol; 2016 Feb; 7(1):9-14. PubMed ID: 26862487
[TBL] [Abstract][Full Text] [Related]
18. Patterns of failure following surgical resection for malignant pleural mesothelioma.
Jänne PA; Baldini EH
Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.
Vincenzi B; Di Maio M; Silletta M; D'Onofrio L; Spoto C; Piccirillo MC; Daniele G; Comito F; Maci E; Bronte G; Russo A; Santini D; Perrone F; Tonini G
PLoS One; 2015; 10(7):e0133488. PubMed ID: 26230853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
